Significant news from Leica today -- CE Mark in Europe for in-vitro diagnostics. With recent news from other manufacturers as well (see: Visiopharm and Omnyx) this news is significant for the digital pathology market and clearances in the...

Exciting news from Visiopharm - their Ki67 diagnostic App has received the CE mark for in-vitro diagnostic use in Europe. The Virtual Double Staining (VDS) Ki67 module for breast is a novel, patented and now CE-marked diagnostic APP intended...

Building on news from last year (see: Omnyx Acquires CE Mark in Europe), Omnyx recently announced more significant news with their approval for their Integrated Digital Pathology (IDP) solution with the new VL120 high volume scanner for...